Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study

Published:2014-08-05 Issue:3 Volume:12 Page:271-280
ISSN:1541-2555
Container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease

Author:

Punekar Yogesh Suresh,Wurst Keele,Shukla Amit

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/15412555.2014.933953

Reference14 articles.

1. Optimizing economic outcomes in the management of COPD

2. A Computer Simulation Model of the Natural History and Economic Impact of Chronic Obstructive Pulmonary Disease

3. Adaptation and validation of the Charlson Index for Read/OXMIS coded databases

4. Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis

5. Economic burden prior to COPD diagnosis: A matched case-control study in the United States

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β₂-agonist dual therapy in a primary care setting in England;BMJ Open Respiratory Research;2022-09

2. Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England;International Journal of Chronic Obstructive Pulmonary Disease;2022-08

3. ЕSTIMATION OF SOCIO-ECONOMIC BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOR A 5-YEAR PERIOD: A REGIONAL ASPECT;Pharmacy & Pharmacology;2021-07-20

Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD – A Detailed Analysis

;International Journal of Chronic Obstructive Pulmonary Disease;2020-09

Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review

;International Journal of Chronic Obstructive Pulmonary Disease;2020-02